All In MedTech

Device Trial Radar · NCT04153292

The ENCIRCLE Trial

SAPIEN M3 System Transcatheter Mitral Valve Replacement Via Transseptal Access

Last checked: Nov 20, 2026Latest source record: Oct 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

786

Actual

Start

Nov 12, 2020

Primary completion

Oct 10, 2027

Study completion Oct 10, 2031

Sponsor

Lead sponsor
Edwards LifesciencesPublic (EW)
Sponsor type
Industry
First posted
Nov 6, 2019

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will establish the safety and effectiveness of the SAPIEN M3 System in subjects with symptomatic, at least 3+ mitral regurgitation (MR) for whom commercially available surgical or transcatheter treatment options are deemed unsuitable. Following completion of enrollment, subjects will be eligible for enrollment in the continued access phase of the trial.

Conditions

  • Mitral Regurgitation
  • Mitral Valve Insufficiency

Interventions

  • SAPIEN M3 valve and dockDevice

    During the procedure a SAPIEN M3 dock and a SAPIEN M3 valve will be implanted via transseptal approach.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Non-hierarchical composite of death and heart failure rehospitalizationTime frame: 1 year

Locations

54 sites in 6 countries. Site status is shown where the registry gives one.

  • Heart Center Hospital

    Huntsville, Alabama

  • Banner University Medical Center

    Phoenix, Arizona

  • Saint Josephs Hospital Medical Center Dignity Health

    Phoenix, Arizona

51 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.